Articles

Many patients and their loved ones find it difficult to discuss end-of-life care with physicians.

A new study shows that chemotherapy can induce changes in the brain that may affect concentration and memory.

A team of researchers has determined a molecular basis for the potential cancer-preventive effects of vitamin D.

A common and potentially long-lasting side effect of cancer and cancer treatment, fatigue may last for months or years.

Cancer-fighting foods are abundant during autumn.

Beyond size, the quality of personal relationships is also important to survival in patients with breast cancer.

Risk of heart failure is even greater for those patients treated with adjuvant trastuzumab.

One of the most frequent sites of metastases for patients diagnosed with lung cancer is the bone, with an estimated 30% to 40% of patients with non–small cell lung cancer developing bone loss.

In this month’s issue of The Oncology Pharmacist (TOP), we continue our coverage of the news from the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO) by addressing the topic of chemotherapy dosing for patients who are obese.

Identifying agents that can prevent chemotherapy-induced peripheral neuropathy (CIPN) is a work in progress. Studies of some interventions suggest modestly encouraging findings, but research on prevention has been hampered by a poor understanding of the different mechanisms of this toxicity with the various chemotherapy agents that induce CIPN.¹